Income StatementBalance SheetCash FlowSegments
STERIS logo

STERIS Business Segments

Business, geographic, and product segment breakdowns

STERIS generates $5.9B in annual revenue across 3 key segments: AST ($552.8M), Healthcare Segment ($2.4B), and Life Sciences: ($65.6M). The company-wide operating margin is 18.56%. Based on the Q1 2026 filing.

AST (TTM)$552.8MHealthcare Segment (TTM)$2.4BLife Sciences:$65.6M
Latest FilingQ1 2026
Report Date2026-05-29
Market Cap$20.9B
P/E Ratio26.67
ROE11.35%

Products & Services

Revenue

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Consumables$426.9M$428.8M$434.2M$451.4M$463.0M$456.2M
Capital equipment$290.9M$370.9M$255.5M$293.4M$315.6M$387.0M

Cost of Product and Service Sold

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Product$371.7M$433.4M$359.7M$390.8M$418.2M$456.8M
Service$388.5M$405.9M$403.4M$423.6M$422.5M$434.4M

Total revenues

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Service$652.7M$680.7M$701.4M$715.3M$717.6M$745.0M

Geographic

Property, Plant and Equipment, Net

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
UNITED STATES—$1.0B$1.0B$1.1B$1.1B$1.1B
IRELAND—$74.9M$82.4M$85.2M$90.5M$88.1M
Other locations—$872.9M——$967.8M—

Revenue

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
UNITED STATES$1.0B$1.1B$1.0B$1.1B$1.1B$1.1B
IRELAND$24.1M$38.2M$22.5M$27.3M$26.7M$31.9M
Other locations$343.9M———$382.3M—

Business Segments

Total Assets

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
AST—$3.3B$3.5B$3.5B$3.6B$3.6B

Cost of Revenue

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Healthcare Segment$552.4M$599.2M$557.4M$592.1M$615.6M$657.4M
AST$127.9M$138.8M$129.9M$139.6M$141.1M$142.2M
Life Sciences:$60.9M——$66.4M$65.6M—

Depreciation, Depletion and Amortization

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
AST$38.4M$36.5M$36.3M$38.9M$40.0M$41.6M

Operating Income (Loss), Before Adjustments

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Healthcare Segment$246.9M$279.7M$235.5M$259.5M$258.1M$283.3M
AST$115.8M$122.2M$136.7M$127.7M$129.2M$131.1M
Life Sciences:$58.1M———$61.8M—

Payments to Acquire Productive Assets

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
AST$56.8M$56.8M$59.6M$59.6M$59.6M$59.6M
Applied Sterilization Technologies$63.9M$45.7M$49.2M$74.1M$55.7M—

R&D

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Healthcare Segment$23.2M$23.7M$22.7M$24.3M$25.2M$25.3M
AST$1.2M$1.1M$900.0K$700.0K$800.0K$800.0K
Life Sciences:$2.4M——$2.7M$2.8M—

Revenue

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Healthcare Segment$976.0M$1.1B$974.7M$1.0B$1.1B$1.1B
AST$258.1M$273.9M$281.2M$281.5M$286.6M$289.2M
Life Sciences:$136.4M——$145.0M$145.8M—

Segment operating income

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Applied Sterilization Technologies$115.8M——$127.6M$129.2M—
Corporate-$100.8M——-$109.9M-$106.0M—
Healthcare$246.9M———$258.1M—
Life Sciences:$58.1M——$59.9M$61.8M—
Segment operating income$320.0M——$337.1M$343.1M—

Selling, general, and administrative

SegmentQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Healthcare Segment$153.5M$154.6M$159.1M$157.9M$164.8M$170.5M
AST$13.3M$11.9M$13.7M$13.5M$15.4M$15.1M
Life Sciences:$15.0M——$16.1M$15.6M—